Trial
NCT05164666
A Study of TAK-103 in Adult With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Solid Tumors
Intervention
TAK-103
Why stopped
Business decision unrelated to patient safety
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29